Pfizer Inc. Pfizer Inc. Company Profile

21:06 EDT 26th April 2018 | BioPortfolio

News Articles [1235 Associated News Articles listed on BioPortfolio]

Biosimilars Council Sides with Pfizer in Antitrust Dispute with J&J

As we previously reported , on September 20, 2017, Pfizer filed an antitrust lawsuit against Johnson & Johnson in the U.S. District Court for the Eastern District of Pennsylvania alleging that J&a...

Pfizer might buy BMS for $130bn – but should it?

Pfizer could soon launch a multi-billion dollar bid for immunotherapy rivals Bristol-Myers Squibb. But moves into new fields of innovation and digital tech – such as Roche’s buyout of Flatiron - a...

FDA Panel Backs Pfizer's Xeljanz For Ulcerative Colitis

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) Thursday announced a favorable outcome of U.S. Food and Drug Administration Gastrointestinal Drugs Advisory Committee meeting on Pfizer's supplemental N...

Pfizer Sells Stake in Chinese JV with Hisun

US pharmaceutical giant Pfizer has divested its 49% stake in Hisun-Pfizer Pharmaceuticals its Chinese joint venture with Zhejiang Hisun Pharma. As part of the plan, Sapphire I Holdings, which is indir...

FDA Approves Diabetes Treatments Developed In Merck-Pfizer Collaboration

NewsMerck and Pfizer will share potential revenues and certain costs on a 60/40 percent basis, respectively, and Pfizer may be entitled to additional milestone payments.

Pfizer (PFE) Set to Announce Earnings on Monday

Pfizer is scheduled to be posting its quarterly earnings results before the market opens on Monday, January 29th. Pfizer has set its FY17 guidance at $2.58-2.62 EPS.

Pfizer To Hold 25% Ownership Stake In Allogene Therapeutics

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) and Allogene Therapeutics Inc. said that they have entered into an asset contribution agreement for Pfizer's portfolio of assets related to allogeneic c...

Pfizer and Allogene in Cancer Therapy Pact

Pfizer and Allogene have entered into an agreement to develop allogeneic chimeric antigen receptor T cell (CAR T) therapy for treating cancer. The deal will see Pfizer take a 25% stake in Allogene, wh...

Drugs and Medications [192 Associated Drugs and Medications listed on BioPortfolio]

Preparation h [Pfizer Consumer Healthcare]

Preparation H Suppositories(cocoa butter and phenylephrine HCl)

Chapstick overnight [Pfizer Consumer Healthcare]

ChapStick Overnight Lip Treatment (dimethicone)

Preparation h [Pfizer Consumer Healthcare]

Preparation H Hemorrhoidal Ointment (mineral oil, petrolatum and phenylephrine HCl)

Anbesol cold sore therapy [Pfizer Consumer Healthcare]

Anbesol Cold Sore Therapy(allantoin, benzocaine, camphor, and white petrolatum)

Chapstick lipshield 365 [Pfizer Consumer Healthcare]

Chapstick LipShield 365(avobenzone, dimethicone, homosalate, octinoxate, octisalate, and oxybenzone)

PubMed Articles [10 Associated PubMed Articles listed on BioPortfolio]

Ertugliflozin: First Global Approval.

Ertugliflozin (Steglatro™) is an orally active sodium glucose co-transporter type 2 inhibitor being developed by Merck and Pfizer as a treatment for type 2 diabetes mellitus (T2DM). Ertugliflozin as...

Irvine-Gass Macular Edema Responding to the Combination of Oral Mineralocorticoid-Receptor Antagonist With Dexamethasone Drops.

Long-lasting postoperative macular edema is a therapeutic challenge. The authors report an efficient combination therapy of oral mineralocorticoid receptor antagonists (eplerenone [Inspra; Pfizer, New...

Donated chemical probes for open science.

Potent, selective and broadly characterized small molecule modulators of protein function (chemical probes) are powerful research reagents. The pharmaceutical industry has generated many high-quality ...

Does BCA3 Play a Role in the HIV-1 Replication Cycle?

The cellular role of breast carcinoma-associated protein (BCA3), also known as A-kinase-interacting protein 1 (AKIP-1), is not fully understood. Recently, we reported that full-length, but not C-termi...

Myostatin inhibition using mRK35 produces skeletal muscle growth and tubular aggregate formation in wild type and TgACTA1D286G nemaline myopathy mice.

Nemaline myopathy (NM) is a heterogeneous congenital skeletal muscle disease with cytoplasmic rod-like structures (nemaline bodies) in muscle tissue. While weakness in NM is related to contractile abn...

Clinical Trials [81 Associated Clinical Trials listed on BioPortfolio]

Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials (REFLECTIONS B328-04)

This extension study will evaluate the safety (including immunogenicity) of treatment with rituximab-Pfizer, as well as the safety and immunogenicity after transitioning from rituximab-US ...

A Study Comparing Blood Levels After Single-Dose Administration Of Artesunate Sachets (Pfizer) Versus Single-Dose Administration Of Arsuamoon® Tablets (Guilin-China) In Healthy Subjects

The primary objective of the study is to determine bioequivalence of 50 mg (2x25 mg) Artesunate Sachet (Pfizer) versus 50 mg (1x50 mg) tablet, Arsuamoon® (Guilin China) which is the World...

A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07))

This is a Phase 1, double blind (sponsor open), randomized (1:1:1), parallel group, 3 arm, single dose comparative PK study of adalimumab Pfizer and adalimumab sourced from the US and EU a...

A Bioequivalence Study Comparing Amodiaquine Tablet (Pfizer) To Amodiaquine Tablets (Arsuamoon-Guilin China) In Healthy Subjects

The study will determine if amodiaquine tablet (Pfizer), an antimalaria agent, is pharmaceutically equivalent to a comparator product (Arsuamoon-Guilin China).

Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fed Conditions

An open label, randomized, single-center, single-dose, two-treatment, two-period, crossover bioavailability study comparing Cetirizine Hydrochloride 10 mg tablet of Ohm Laboratories Inc. ...

Companies [118 Associated Companies listed on BioPortfolio]

The Pfizer Foundation

The Pfizer Foundation is a charitable organization established by Pfizer Inc. The Foundation is a separate and independent tax-exempt organization. The Foundation’s mission i...

Renata Limited

Historical High-Lights: Founded in 1972 as a subsidiary of Pfizer Inc. Ownership transferred from Pfizer Inc. to local institutions and the general public in 1993. Company name subsequently changed fr...

Pfizer Ophthalmics

Pfizer Ophthalmics, a division of Pfizer Inc, is committed to preserving sight and eliminating preventable blindness. Pfizer Ophthalmics discovers, develops and provides leading treatments in ophthalm...

Bristol-Myers Squibb Company & Pfizer Inc.

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize ELIQUIS, an investigational oral anticoagulant discovered by Bristol-M...

Pfizer Consumer Healthcare

Centrum Silver

More Information about "Pfizer Inc. Pfizer Inc." on BioPortfolio

We have published hundreds of Pfizer Inc. Pfizer Inc. news stories on BioPortfolio along with dozens of Pfizer Inc. Pfizer Inc. Clinical Trials and PubMed Articles about Pfizer Inc. Pfizer Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pfizer Inc. Pfizer Inc. Companies in our database. You can also find out about relevant Pfizer Inc. Pfizer Inc. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record